Comorbidity of substance use disorders with mood and anxiety disorders
about
Playing video games while using or feeling the effects of substances: associations with substance use problemsThe relationship of appetitive, reproductive and posterior pituitary hormones to alcoholism and craving in humansThe Personality Trait of Intolerance to Uncertainty Affects Behavior in a Novel Computer-Based Conditioned Place Preference Task.Predictors of benzodiazepine discontinuation in subjects manifesting complicated dependenceEffects of drug abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected personsThe underlying neurobiology of key functional domains in young people with mood and anxiety disorders: a systematic review.Social cognition deficits and psychopathic traits in young people seeking mental health treatment.Comorbidity for alcohol use disorders and drug use in mexican-origin groups: comparison of data from national alcohol surveys in the U.S. And Mexico.Symptoms of anxiety and associated risk and protective factors in young Asian American childrenA comparison of recommendations and received treatment for mood and anxiety disorders in a representative national sample.Alcohol use disorders, nicotine dependence, and co-occurring mood and anxiety disorders in the United States and South Korea-a cross-national comparison.Clustering of trauma and associations with single and co-occurring depression and panic attack over twenty yearsComorbid mental disorders in substance users from a single catchment area--a clinical study.Typology of adults diagnosed with mental disorders based on socio-demographics and clinical and service use characteristics.A cross-sectional study of patients with and without substance use disorders in Community Mental Health Centres.Consequences of adolescent drug use on psychiatric disorders in early adulthood.Implications of epidemiological data for identifying persons with substance use and other mental disorders.Substance abuse disorder and major depression are associated with the human 5-HT1B receptor gene (HTR1B) G861C polymorphism.Sub-clinical anxiety and the onset of alcohol use disorders: longitudinal associations from the Baltimore ECA follow-up, 1981-2004.Caregiver burden and depression among informal caregivers of HIV-infected individualsSubstance use disorders assessed using the Kreek-McHugh-Schluger-Kellogg (KMSK) scale in an urban low-income and predominantly African American sample of primary care patients.Substance use disorders: sex differences and psychiatric comorbidities.The effectiveness of integrated treatment in patients with substance use disorders co-occurring with anxiety and/or depression--a group randomized trial.Bidirectional interactions between acute psychosocial stress and acute intravenous alcohol in healthy men.Psychiatric comorbidity in long-term abstinent alcoholic individuals.Hope and Abstinence Self-Efficacy: Positive Predictors of Negative Affect in Substance Abuse RecoverySubstance Use and Depression Symptomatology: Measurement Invariance of the Beck Depression Inventory (BDI-II) among Non-Users and Frequent-Users of Alcohol, Nicotine and CannabisDisentangling psychopathology, substance use and dependence: a factor analysis.Race/ethnicity differences between alcohol, marijuana, and co-occurring alcohol and marijuana use disorders and their association with public health and social problems using a national sample.Cross-sectional survey evaluating Text4Mood: mobile health program to reduce psychological treatment gap in mental healthcare in Alberta through daily supportive text messagesThe Association Between Stimulant, Opioid, and Multiple Drug Use on Behavioral Health Care Utilization in a Safety-Net Health System.Effects of major depression on crack use and arrests among women in drug court.Stress, alcohol and drug interaction: an update of human research.Antecedents and covariates of alcohol consumption among Swiss male conscripts.Mental disorders as risk factors for later substance dependence: estimates of optimal prevention and treatment benefits.Determinants associated with the utilization of primary and specialized mental health services.Web-Based Intervention to Reduce Substance Abuse and Depressive Symptoms in Mexico: Development and Usability Test.Khantzian's 'self-medication hypothesis' of drug addiction and films by Martin Scorsese.Treatment seeking and barriers to treatment for alcohol use in persons with alcohol use disorders and comorbid mood or anxiety disorders.Individual vulnerability to addiction.
P2860
Q24630570-0D593580-140C-4ECA-96C3-A4A3B668788FQ26992207-2207B34C-244F-45F1-8057-0A076A7AA8FDQ27303948-376034BD-5108-4CCE-BA1B-6B719AEA18D5Q28245171-BDF658F7-9B2B-478E-A29E-CD0A5DCB23D2Q28353070-201CFC02-AFE5-4564-81CE-6E3F86467074Q30383143-829938EF-23D7-459F-B97F-B659292462FFQ31123293-C1744A0E-5B23-4704-8BD2-A904170A8AD1Q31133007-6545B757-8CE9-47BD-935D-77884D9DA701Q33564805-A63C789C-0738-4D58-86BE-209A0C1D9D6AQ33630005-8ACA69F7-0A37-4032-869F-C3B6783F08F8Q33671603-2EFDDF03-D195-4238-A042-59C2EF6EF03AQ33774175-50CDDD31-CB2E-47A0-A21C-91D5BBAE44D4Q33818760-9FF9F464-313B-474C-8CEC-5783831590C1Q33877944-682E14D4-239D-4AA9-8D92-40A86F8838DFQ33909153-97C5A038-4801-4575-A593-C39BE194B667Q34058363-4B90E003-3113-4CB5-A993-14EC16642102Q34158450-17BF0C90-385C-4D26-8C7B-F72D1C52ECE1Q34166564-5F377EC6-FD9B-48F1-9A00-200C6DB4ACF1Q34438230-AFA65614-7FBF-41E4-8502-0C0F49E72DC8Q34723249-7F9376E1-D5BA-4FAE-8C0E-34768935C805Q34789481-59D721BF-AA17-477C-AD43-72D89EFA1D67Q35084952-3E42C288-EF99-42A9-859D-51C7D99D8D3FQ35111694-A74B75C9-4F94-4C59-91B3-D3B4596A60F0Q35243826-0385DB0C-0E85-4BEB-BD20-5E2C1A5269ECQ35792826-5F8E474E-54EE-4E5D-A11F-B5B76932E35CQ35892532-C12C689F-1288-48F4-9027-AD03EADA7586Q35979986-35879F34-41D4-4951-AD06-67E65FF5DBBDQ36098113-D23CB1B4-1588-4918-9AF1-B0830DBDB669Q36165046-BA7D86E0-09C5-4FC8-A3E5-7C440409715DQ36184689-C4505109-ED4E-4A62-BD4A-C936CA7B8F76Q36657998-02074393-29E3-4990-9C96-D0A0DD38CB0DQ37012211-F35C336D-C4D4-443C-809C-26A197D72178Q37124698-D8C4E7FC-2E55-416B-A245-3FDDBB525ED9Q37167386-FABDAD4C-74C7-4C7E-A62E-1CF6D014175FQ37249662-5FE1A387-17D5-4790-B220-3C700A624F71Q37256244-FFADCDDB-2AA8-4EC5-B893-EE4CEDC2D739Q37313332-BB13E6D7-5131-4C94-A0A1-B5CFAFC15806Q37491006-8A258C23-D5AD-4806-AF87-227A6E7C36FFQ37697096-C2E0232B-2B3C-45CD-819E-EC1102FF8475Q37832748-A50563BB-FE12-4A30-988D-1A6A122D367D
P2860
Comorbidity of substance use disorders with mood and anxiety disorders
description
article
@en
im November 1998 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 1998
@uk
name
Comorbidity of substance use disorders with mood and anxiety disorders
@en
Comorbidity of substance use disorders with mood and anxiety disorders
@nl
type
label
Comorbidity of substance use disorders with mood and anxiety disorders
@en
Comorbidity of substance use disorders with mood and anxiety disorders
@nl
prefLabel
Comorbidity of substance use disorders with mood and anxiety disorders
@en
Comorbidity of substance use disorders with mood and anxiety disorders
@nl
P2093
P921
P1433
P1476
Comorbidity of substance use d ...... um in Psychiatric Epidemiology
@en
P2093
B E Molnar
E E Walters
J D Swendsen
J J Caraveo-Anduaga
K R Merikangas
R C Kessler
P304
P356
10.1016/S0306-4603(98)00076-8
P577
1998-11-01T00:00:00Z